155 related articles for article (PubMed ID: 31524211)
21. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance.
Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R
Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555
[TBL] [Abstract][Full Text] [Related]
22. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
[TBL] [Abstract][Full Text] [Related]
23. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
[TBL] [Abstract][Full Text] [Related]
24. A new drug carrier with oxygen generation function for modulating tumor hypoxia microenvironment in cancer chemotherapy.
Zhang Z; Niu N; Gao X; Han F; Chen Z; Li S; Li J
Colloids Surf B Biointerfaces; 2019 Jan; 173():335-345. PubMed ID: 30316080
[TBL] [Abstract][Full Text] [Related]
25. Actively targeting D-α-tocopheryl polyethylene glycol 1000 succinate-poly(lactic acid) nanoparticles as vesicles for chemo-photodynamic combination therapy of doxorubicin-resistant breast cancer.
Jiang D; Gao X; Kang T; Feng X; Yao J; Yang M; Jing Y; Zhu Q; Feng J; Chen J
Nanoscale; 2016 Feb; 8(5):3100-18. PubMed ID: 26785758
[TBL] [Abstract][Full Text] [Related]
26. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells.
Du G; Lin H; Wang M; Zhang S; Wu X; Lu L; Ji L; Yu L
Cancer Chemother Pharmacol; 2010 Jan; 65(2):277-87. PubMed ID: 19466611
[TBL] [Abstract][Full Text] [Related]
27. Synchronous delivery of oxygen and photosensitizer for alleviation of hypoxia tumor microenvironment and dramatically enhanced photodynamic therapy.
Guo X; Qu J; Zhu C; Li W; Luo L; Yang J; Yin X; Li Q; Du Y; Chen D; Qiu Y; Lou Y; You J
Drug Deliv; 2018 Nov; 25(1):585-599. PubMed ID: 29461122
[TBL] [Abstract][Full Text] [Related]
28. Development of an interactive tumor vascular suppression strategy to inhibit multidrug resistance and metastasis with pH/H
Du B; Ding X; Wang H; Du Q; Xu T; Huang J; Zhou J; Cheng G
J Mater Chem B; 2019 Aug; 7(31):4784-4793. PubMed ID: 31389949
[TBL] [Abstract][Full Text] [Related]
29. Styrene maleic acid copolymer-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases.
Daruwalla J; Greish K; Malcontenti-Wilson C; Muralidharan V; Maeda H; Christophi C
Surgery; 2015 Jul; 158(1):236-47. PubMed ID: 25999256
[TBL] [Abstract][Full Text] [Related]
30. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable MnFe-hydroxide nanocapsules to enable multi-therapeutics delivery and hypoxia-modulated tumor treatment.
Liao L; Cen D; Fu Y; Liu B; Fang C; Wang Y; Cai X; Li X; Wu HB; Han G
J Mater Chem B; 2020 May; 8(17):3929-3938. PubMed ID: 32232281
[TBL] [Abstract][Full Text] [Related]
32. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein.
Jin Y; Zhang Z; Zhao T; Liu X; Jian L
J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136
[TBL] [Abstract][Full Text] [Related]
33. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle.
Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ
Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin encapsulated in micelles enhances radiosensitivity in doxorubicin-resistant tumor cells.
Xu W; Han M; Diao Y; Pan T; Ge W; Liu H; He H; Jiang H; Zheng S; Zhang S; Gao J; Wei Q
Discov Med; 2014 Oct; 18(99):169-77. PubMed ID: 25336030
[TBL] [Abstract][Full Text] [Related]
36. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
38. Sequential Intercellular Delivery Nanosystem for Enhancing ROS-Induced Antitumor Therapy.
Wang B; Zhang H; An J; Zhang Y; Sun L; Jin Y; Shi J; Li M; Zhang H; Zhang Z
Nano Lett; 2019 Jun; 19(6):3505-3518. PubMed ID: 31034238
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species.
Wartenberg M; Ling FC; Müschen M; Klein F; Acker H; Gassmann M; Petrat K; Pütz V; Hescheler J; Sauer H
FASEB J; 2003 Mar; 17(3):503-5. PubMed ID: 12514119
[TBL] [Abstract][Full Text] [Related]
40. Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing.
Ngoune R; Contini C; Hoffmann MM; von Elverfeldt D; Winkler K; Putz G
Curr Drug Deliv; 2018; 15(9):1261-1270. PubMed ID: 29779479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
